A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT.
Matt Kaeberlein, the CEO of Optispan, shared his longevity habits. Matt Kaeberlein Matt Kaeberlein, a longevity researcher and CEO of Optispan, had symptoms of low testosterone. He got his levels…
Perspective Analysis
Comparing sources…
How outlets covered this
Left-leaning
No articles
Center
Right-leaning
No articles
Coverage Timeline
Read at source (2 outlets)
A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT.
Read full article →A longevity researcher started taking testosterone in his 50s. He says there are 4 things everyone should know before considering TRT.
Matt Kaeberlein, the CEO of Optispan, shared his longevity habits. Matt Kaeberlein Matt Kaeberlein, a longevity researcher and CEO of Optispan, had symptoms of low testosterone. He got his levels tested in his 50s and gradually began testosterone replacement therapy (TRT). He said everyone should know 4 things before starting TRT. In 2020, longevity researcher Matt Kaeberlein started wondering if he had low testosterone levels. Then, in his early 50s, Kaeberlein had all the classic symptoms...
Read full article →Related Stories
AI in healthcare: A partner, not a replacement for doctors
5m ago
Over 220 million children will suffer from obesity by 2040
10m ago
Salvation Army launches $1.5 million meth harm reduction programme in Motueka
28m ago
More than 220m children will be obese by 2040 without drastic action, report warns
47m ago